QA: Akari Therapeutics Plc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001541157_2016_Akari_Therapeutics_Plc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001541157, Akari Therapeutics Plc

  xvar xval
0 AssetsCurrent 69,658,487
1 IntangibleAssetsNetIncludingGoodwill 52,483
2 PropertyPlantAndEquipmentNet 40,513
3 remainder_Assets 142,079
4 LiabilitiesCurrent 21,124,968
5 LiabilitiesNoncurrent 49,069
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,502,214
9 ResearchAndDevelopmentExpense 5,799,076
10 remainder_Expenses 19,283,280
11 remainder_Revenues 0
12 remainder_NetIncome -14,732,962
13 remainder_ComprehensiveNetIncome 110,399
  yvar yval
0 Assets 69,893,562
1 Liabilities 21,174,037
2 Expenses 30,584,570
3 Revenues 0
4 StockholdersEquity 48,719,525
5 NetIncome -45,317,532
6 ComprehensiveNetIncome -45,262,332
7 BaseVar 68,247,765
8 EconomicCapitalRatiobeforeLimitedLiability 1.34
9 EconomicCapitalRatio 2.56

Edgar->Model Mapping

Feature Distribution